Bildkälla: Stockfoto

Active Biotech: Rights Issue Oversubscribed - Redeye

Redeye comments on Active Biotech's 2024 rights issue and updates its base case.

Redeye comments on Active Biotech's 2024 rights issue and updates its base case.
Börsvärldens nyhetsbrev
ANNONSER